The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Effects on Cue Reactivity in Response to Virtual Reality Public Speaking Environment.

Trial Profile

The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Effects on Cue Reactivity in Response to Virtual Reality Public Speaking Environment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2010

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Social phobia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2007 Status changed from recruiting to completed.
    • 01 Feb 2007 Status changed from initiated
    • 12 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top